Optiver Holding B.V. Cure Vac N.V. Transaction History
Optiver Holding B.V.
- $2.48 Billion
- Q1 2025
A detailed history of Optiver Holding B.V. transactions in Cure Vac N.V. stock. As of the latest transaction made, Optiver Holding B.V. holds 4,717 shares of CVAC stock, worth $25,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,717
Previous 190
2382.63%
Holding current value
$25,518
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CVAC
# of Institutions
94Shares Held
10.4MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$12.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.82MShares$9.83 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.49 Million10.6% of portfolio
-
Ubs Group Ag843KShares$4.56 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL280KShares$1.51 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.01B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...